Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial-Reference-Cited by-同舟云学术

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

Published:2009-01 Issue:1 Volume:8 Page:39-47
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Burns Alistair,Bernabei Roberto,Bullock Roger,Jentoft Alfonso J Cruz,Frölich Lutz,Hock Christoph,Raivio Minna,Triau Eric,Vandewoude Maurits,Wimo Anders,Came Elizabeth,Van Baelen Bart,Hammond Gerry L,van Oene Joop C,Schwalen Susanne

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference32 articles.

1. Number of dementia sufferers in Europe between the years 2000 and 2050;Wancata;Eur Psychiatry,2003

2. Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment;Desai;CNS Drugs,2004

3. Patient and caregiver characteristics and nursing home placement in patients with dementia;Yaffe;JAMA,2002

4. Determinants of costs of care for patients with Alzheimer's disease;Jönsson;Int J Geriatr Psychiatry,2006

5. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease;Maelicke;Eur J Pharmacol,2000

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer’s disease: A systematic review and meta-analysis;Advances in Clinical and Experimental Medicine;2024-03-01

2. Anti-dementia drugs: what is the evidence in advanced stages?;Porto Biomedical Journal;2024-03

3. Efficacy of exercise rehabilitation for managing patients with Alzheimer’s disease;Neural Regeneration Research;2023-12-21

4. The influence of heat stress on the antioxidant protection glutathione link and the content of lipid peroxidation products in chicken liver;The Animal Biology;2023-12

5. Cholinesterase inhibitors and falls, syncope and injuries in patients with cognitive impairment: a systematic review and meta-analysis;Age and Ageing;2023-11-02